US2009133633A1PendingUtilityA1
In ovo activation of an egg in the shell
Est. expiryFeb 15, 2020(expired)· nominal 20-yr term from priority
A01K 45/007A01K 67/02A61D 19/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the field of avian reproduction. In particular, the present invention provides a method of activating an egg in a shell. The invention also provides a method of activating an egg in a shell, whereby a live chick is hatched.
Claims
exact text as granted — not AI-modified1 - 87 . (canceled)
88 . A method of producing a live chick from an oviposited unfertilized avian egg in the shell, wherein the live chick contains heterologous nucleic acid, wherein the egg comprises a yolk enclosed by a membrane and an ovum, wherein the method comprises:
a) activating the ovum; b) introducing heterologous nucleic acid into the egg; and c) incubating the egg until hatching.
89 . The method of claim 88 , wherein the heterologous nucleic acid encodes a pharmaceutical protein, an antigen, a hormone or an antibody.
90 . The method of claim 88 , wherein the heterologous nucleic acid comprises Avian Leukemia Virus-derived transducing particles.
91 . The method of claim 88 , wherein the heterologous nucleic acid encodes a protein.
92 . The method of claim 88 , wherein the heterologous nucleic acid is stably integrated into the avian genome.
93 . A method of producing a live chick from an oviposited unfertilized avian egg in the shell, wherein the live chick contains heterologous nucleic acid, wherein the egg comprises a yolk enclosed by a membrane and an ovum, wherein the method comprises:
a) activating the ovum by delivering a sperm sample comprising avian sperm in a physiologically acceptable carrier into the egg; b) introducing heterologous nucleic acid into the egg; and c) incubating the egg until hatching.
94 . The method of claim 93 , wherein the heterologous nucleic acid encodes a pharmaceutical protein, an antigen, a hormone or an antibody.
95 . The method of claim 93 , wherein the heterologous nucleic acid comprises Avian Leukemia Virus-derived transducing particles.
96 . The method of claim 93 , wherein the heterologous nucleic acid encodes a protein.
97 . The method of claim 93 , wherein the heterologous nucleic acid is stably integrated into the avian genome.Join the waitlist — get patent alerts
Track US2009133633A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.